Lista de obras - Marc-Eric Halatsch - Dominio Público Uruguay

A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen

artículo científico publicado en 2020

A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy

artículo científico publicado en 2015

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

artículo científico publicado en 2013

A paired comparison between glioblastoma "stem cells" and differentiated cells

artículo científico publicado en 2015

ACTR-44. PRELIMINARY RESULTS FROM THE NCT02770378 PROOF-OF-CONCEPT CLINICAL TRIAL ASSESSING THE SAFETY OF THE CUSP9v3 PROTOCOL COMBINED WITH METRONOMIC TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

artículo científico publicado en 2018

An ultrasound study of brain tissue biomechanics in patients following craniectomy

artículo científico publicado en 2009

Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification

artículo científico

Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines

artículo científico publicado en 2014

Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

artículo científico publicado en 2018

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma.

artículo científico publicado en 2017

Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma

scientific article published on 30 July 2019

Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach

artículo científico publicado en 2018

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen

artículo científico publicado en 2017

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

artículo científico publicado en 2014

Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin? ⬇️

artículo científico publicado el 1 de noviembre de 2011

Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells

artículo científico publicado en 2017

Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation

artículo científico publicado en 2009

Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells

artículo científico publicado en 2016

Cell Death Induction in Cancer Therapy - Past, Present, and Future

artículo científico publicado en 2016

Characteristics of thoracolumbar intramedullary subependymomas

artículo científico publicado en 2009

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.

artículo científico publicado en 2004

Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo

artículo científico publicado en 2015

Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells

artículo científico publicado en 2013

Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis

artículo científico publicado en 2019

Compare and contrast: pediatric cancer versus adult malignancies

artículo científico publicado en 2019

Congenital duplication of the superior sagittal sinus and parietal encephalocele after vacuum extraction delivery

artículo científico publicado en 2009

Drug combinations enhancing the antineoplastic effects of erlotinib in high-grade glioma

scientific article published on September 2011

Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma

artículo científico publicado en 2020

ET-26COMBINED TREATMENT WITH ABT263 AND GX15-070 YIELDS A SYNERGISTIC ANTIPROLIFERATIVE EFFECT IN GLIOBLASTOMA.

artículo científico publicado en 2014

EXTH-45. THE REPURPOSED CUSP9 REGIMEN EXERTS POTENT ANTI-NEOPLASTIC ACTIVITY AGAINST GLIOBLASTOMA CELLS IN VITRO

EXTH-54. Bcl-2/Bcl-xL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO

EXTH-55. CONCOMITANT INHIBITION OF RAC1 AND Bcl-2/Bcl-xL INTERFERES WITH THE Mcl-1/Usp9X AXIS AND YIELDS SYNERGISTIC ANTI-GLIOMA ACTIVITY

EXTH-79. INITIAL EXPERIENCES WITH COMPASSIONATE-USE CUSP9v3/v4 FOR RECURRENT GLIOBLASTOMA

Editorial: targeted therapy for glioblastoma multiforme

artículo científico publicado en 2011

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

artículo científico publicado en 2006

Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma

artículo científico publicado en 2012

Erlotinib in glioblastoma: lost in translation?

artículo científico publicado en 2011

Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells

scientific article published on 28 October 2016

First Report of Recurrent Intramuscular Lipoma after Decompression Surgery of the Lumbar Spine

artículo científico publicado en 2015

Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin

artículo científico publicado en 2017

Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma

artículo científico publicado en 2013

Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells

scientific article published on 16 August 2018

Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo

artículo científico publicado en 2016

Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines

artículo científico publicado en 2004

Irrigation can cause prolonged intracranial pressure elevations during endoscopic treatment of intraventricular haematomas

artículo científico publicado en 2011

Lactoferrin Is an Allosteric Enhancer of the Proteolytic Activity of Cathepsin G.

artículo científico publicado en 2016

Lumbar subdural haematoma after temporomesial resection in epilepsy patients--report of two cases and review of the literature

artículo científico publicado en 2007

MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

artículo científico publicado en 2022

Matrix metalloproteinase-2 and -9 in glioblastoma: a trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma

artículo científico publicado en 2012

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo

scientific article published on 09 May 2016

Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma.

artículo científico publicado en 2017

Molecular modes of action of artesunate in tumor cell lines.

artículo científico publicado en 2003

Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines

artículo científico publicado en 2002

Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome

artículo científico publicado en 2009

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect

artículo científico publicado en 2014

PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma

artículo científico publicado en 2014

Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib.

artículo científico publicado en 2008

Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy

artículo científico publicado en 2014

RARE-09. MINIMALLY TOXIC MULTIMODAL AND POLYPHARMACOLOGICAL THERAPY IN TREATMENT OF DIFFUSE MIDLINE GLIOMA

RIST: a potent new combination therapy for glioblastoma

artículo científico publicado en 2014

Rare Case of Sporadic Malignant Optic Pathway Glioma in 71-Year-Old Woman

artículo científico publicado en 2019

Real-time ultrasound monitoring during intracranial needle biopsies: operative results and detection of complications in 100 cases

artículo científico publicado en 2013

Response to Cervical Medial Branch Blocks In Patients with Cervicogenic Vertigo

Response to transforaminal injection of steroids and correlation to mri findings in patients with cervical radicular pain or radiculopathy due to disc herniation or spondylosis

artículo científico publicado en 2014

Ribozyme-mediated inhibition of 801-bp deletion-mutant epidermal growth factor receptor mRNA expression in glioblastoma multiforme.

artículo científico publicado en 2010

Specific patterns of DNA copy number gains and losses in eight new glioblastoma multiforme cell lines.

artículo científico publicado en 2003

Symmetrical intracerebral and intracerebellar calcification ("Fahr's disease").

artículo científico publicado en 2005

TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo

artículo científico publicado en 2015

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma

artículo científico

The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy

artículo científico publicado en 2017

The effects of PI3K-mediated signalling on glioblastoma cell behaviour

artículo científico publicado en 2017

The limitations of targeting MEK signalling in Glioblastoma therapy

scientific article published on 04 May 2020

The rationale of targeting neutrophils with dapsone during glioblastoma treatment

artículo científico publicado en 2011

Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?

artículo científico publicado en 2009

Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen

artículo científico publicado en 2016

Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.

artículo científico publicado en 2006

Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acids

artículo científico publicado en 2018

Why dapsone stops seizures and may stop neutrophils’ delivery of VEGF to glioblastoma ⬇️

artículo científico publicado el 2 de mayo de 2012

[Intraoperative magnetic resonance imaging. Fifteen years' experience in the neurosurgical hybrid operating suite].

artículo científico publicado en 2012

Lista de obras de Marc-Eric Halatsch

A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen

A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

A paired comparison between glioblastoma "stem cells" and differentiated cells

ACTR-44. PRELIMINARY RESULTS FROM THE NCT02770378 PROOF-OF-CONCEPT CLINICAL TRIAL ASSESSING THE SAFETY OF THE CUSP9v3 PROTOCOL COMBINED WITH METRONOMIC TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

An ultrasound study of brain tissue biomechanics in patients following craniectomy

Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification

Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines

Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma.

Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma

Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin? ⬇️

Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells

Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation

Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells

Cell Death Induction in Cancer Therapy - Past, Present, and Future

Characteristics of thoracolumbar intramedullary subependymomas

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.

Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo

Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells

Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis

Compare and contrast: pediatric cancer versus adult malignancies

Congenital duplication of the superior sagittal sinus and parietal encephalocele after vacuum extraction delivery

Drug combinations enhancing the antineoplastic effects of erlotinib in high-grade glioma

Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma

ET-26COMBINED TREATMENT WITH ABT263 AND GX15-070 YIELDS A SYNERGISTIC ANTIPROLIFERATIVE EFFECT IN GLIOBLASTOMA.

EXTH-45. THE REPURPOSED CUSP9 REGIMEN EXERTS POTENT ANTI-NEOPLASTIC ACTIVITY AGAINST GLIOBLASTOMA CELLS IN VITRO

EXTH-54. Bcl-2/Bcl-xL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO

EXTH-55. CONCOMITANT INHIBITION OF RAC1 AND Bcl-2/Bcl-xL INTERFERES WITH THE Mcl-1/Usp9X AXIS AND YIELDS SYNERGISTIC ANTI-GLIOMA ACTIVITY

EXTH-79. INITIAL EXPERIENCES WITH COMPASSIONATE-USE CUSP9v3/v4 FOR RECURRENT GLIOBLASTOMA

Editorial: targeted therapy for glioblastoma multiforme

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma

Erlotinib in glioblastoma: lost in translation?

Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells

First Report of Recurrent Intramuscular Lipoma after Decompression Surgery of the Lumbar Spine

Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin

Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma

Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells

Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo

Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines

Irrigation can cause prolonged intracranial pressure elevations during endoscopic treatment of intraventricular haematomas

Lactoferrin Is an Allosteric Enhancer of the Proteolytic Activity of Cathepsin G.

Lumbar subdural haematoma after temporomesial resection in epilepsy patients--report of two cases and review of the literature

MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

Matrix metalloproteinase-2 and -9 in glioblastoma: a trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo

Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma.

Molecular modes of action of artesunate in tumor cell lines.

Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines

Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect

PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma

Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib.

Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy

RARE-09. MINIMALLY TOXIC MULTIMODAL AND POLYPHARMACOLOGICAL THERAPY IN TREATMENT OF DIFFUSE MIDLINE GLIOMA

RIST: a potent new combination therapy for glioblastoma

Rare Case of Sporadic Malignant Optic Pathway Glioma in 71-Year-Old Woman

Real-time ultrasound monitoring during intracranial needle biopsies: operative results and detection of complications in 100 cases

Response to Cervical Medial Branch Blocks In Patients with Cervicogenic Vertigo

Response to transforaminal injection of steroids and correlation to mri findings in patients with cervical radicular pain or radiculopathy due to disc herniation or spondylosis

Ribozyme-mediated inhibition of 801-bp deletion-mutant epidermal growth factor receptor mRNA expression in glioblastoma multiforme.

Specific patterns of DNA copy number gains and losses in eight new glioblastoma multiforme cell lines.

Symmetrical intracerebral and intracerebellar calcification ("Fahr's disease").

TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma

The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy

The effects of PI3K-mediated signalling on glioblastoma cell behaviour

The limitations of targeting MEK signalling in Glioblastoma therapy

The rationale of targeting neutrophils with dapsone during glioblastoma treatment

Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?

Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen

Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.

Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acids

Why dapsone stops seizures and may stop neutrophils’ delivery of VEGF to glioblastoma ⬇️

[Intraoperative magnetic resonance imaging. Fifteen years' experience in the neurosurgical hybrid operating suite].